iPSC-derived Monocytes with Media

Cat.-Nr.: ASE-9745

Description

Take advantage of 25% off on these iPSC-derived Cells with Media – offer ends December 31, 2025

Applied StemCell has developed an efficient, integration-free, small-molecule-based method to differentiate high-quality monocytes from human iPSCs. The differentiated monocytes recapitulate the phenotype and functional parameters of primary and in vivo monocytes.

We provide monocytes differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from the fibroblasts of an African American male donor. These high-purity (>90%) cells express high levels of monocyte biomarkers CD14.

These iPSC-differentiated monocytes can be used as control lines to compare the phenotype and functionality of patient-derived, genome-edited iPSC-derived monocytes for drug screening applications.

For an overview of available hematopoietic cells and isolated subsets from all available sources (leukapheresis, periperal blood, cord blood, bone marrow and iPSC-derived), see the product list: Human Hematopoietic Cells (click).

 

  • SUPPLIER:

    Applied StemCell

  • STATUS:

    In Stock

  • SIZE:

    kit

Overview

iPSC-derived Monocytes with Media (iPSCs from Fibroblasts, iPSC Line ASE-9211, African-American Male, Neonatal)
  • Species: Human
  • Keywords: iPSC-derived cells
  • iPSC: iPSC-Derived T Cells
  • Features: cryopreserved, male
  • Cell Type: Hematopoietic cells

Related Files

Datasheet

RELATED PRODUCTS


Human D-DimerHigh Concentration Rat Tail Collagen 10 mg/mL